Skip to main content
SpringerLink
Log in

Fingerkuppennekrosen nach Dihydroergotaminmedikation bei limitierter systemischer Sklerodermie

  • Farbbildkasuistik
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Bei einer 78jährigen Patientin mit limitierter systemischer Sklerodermie kam es nach Einnahme von Angionorm (Dihydroergotamin) bereits nach wenigen Tagen zu einer akuten Entwicklung von Fingerkuppennekrosen. Diese heilten nach Absetzen des Medikamentes innerhalb von 3 Wochen wieder ab. Hohes Lebensalter und vorbestehende Mikroangiopathie sind Kontraindikationen für die Anwendung Ergotamin-haltiger Präparate.

Summary

A 78 year old women developed acute fingertip necrosis just a few days after starting dihydroergotamine. The lesions healed in 3 weeks after the medication was stopped. The patient had suffered from Raynaud syndrome for 5 years and limited systemic sclerosis was diagnosed during the necrotic episode. Advanced age and microangiopathies are contraindications to the use of ergot-containing preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Klinik für Dermatologie und Allergologie, Augsburg (Direktor: Prof. Dr. Prof. h.c. B.-R. Balda), , , , , , XX

    Torsten Hahne & Bernd-Rüdiger Balda

Authors
  1. Torsten Hahne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernd-Rüdiger Balda
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Eingegangen am 15. Mai 1997 Angenommen am 27. August 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hahne, T., Balda, BR. Fingerkuppennekrosen nach Dihydroergotaminmedikation bei limitierter systemischer Sklerodermie. Hautarzt 49, 722–724 (1998). https://doi.org/10.1007/s001050050816

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001050050816

Search

Navigation